Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Acticor, Aquestive, Atyr, Aura, Bergenbio, Bio-Thera, Cinrx, Cornerstone, Equillium, Harbour, Ichnos, Kempharm, Medicenna, Modus, Neurosense, Neurophth, Nykode, Ocular, Odyssey, Oncternal, Pepgen, Rallybio, Synthetic Biologics, TCR2, Telix, X4.